[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:cryptogenic-stroke":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":40,"states":41},"Cryptogenic stroke",5,4,[8,15,21,27,33],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT05537753","Encore PFO Closure Device - The PerFOrm Trial",[],"RECRUITING","2026-08-26T02:17:10.213717Z","2026-05-05T02:43:28.014828Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT07420400","Non-Invasive Detection of Right-to-Left Cardiac Shunts",[],"2026-08-26T02:18:27.904411Z","2026-05-13T02:55:06.701337Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT07224178","Left Atrial Strain and Cryptogenic Stroke",[],"2026-08-26T02:17:05.997056Z","2026-05-13T02:55:06.677529Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT07172464","Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study",[],"2026-08-26T02:15:10.362237Z","2026-05-05T02:43:28.495743Z",{"nct_id":34,"title":35,"phases":36,"status":37,"updated_at":38,"content_modified":39},"NCT06398366","Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:21.385056Z","2026-06-16T05:54:07.750285Z",[],[42],{"state":43,"count":44,"slug":45},"California",3,"california"]